Is it time to combine osteoporosis therapies?
- PMID: 23683601
- PMCID: PMC7155427
- DOI: 10.1016/S0140-6736(13)60984-8
Is it time to combine osteoporosis therapies?
Abstract
Background: Setting up a clinical study can take more than 18 months and can cost millions of pounds. For many aspects of global health there is a dearth of research, yet evidence is urgently needed to address major challenges. Obtaining such data within a meaningful timeframe requires a fundamental change in the planning and setting up of research studies. Typically, protocols are developed in closed groups and often never shared. However, many operational processes in research are generic, irrespective of the disease or design. Thus, removal of duplication and sharing methods could speed up research. This research methodology project investigates whether researchers can be persuaded to share methods and if this will streamline research.
Methods:
The theory of communities of practice (in which distinct specialists working on a problem collaborate to solve it) guided this project.
Findings: Since 2011, more than 60 000 researchers, nurses, technicians, and scientists from almost all low-income and middle-income countries have used the project to share research methods, knowledge, and processes. 21 specialised communities of practice have formed collaborations that are actively exchanging methods. More than 250 research guidance notes have been shared that provide specific guidance for various research methods—eg, an international respiratory disease network has released three open-access novel coronavirus protocols and groups working in maternal health are listing the samples they have stored with the invitation for others to collaborate. These qualitative and quantitative data show that these exchanges are highly beneficial for guiding and improving research operations, and that there is a willingness to share.
Interpretation: Scientists compete for funding and publication and therefore sharing methods and knowledge can be perceived as disadvantageous. However, if use of protocols and methods developed by wide and open consensus can help to quickly gain high quality data, then better progress could be made for all and disease research could be changed to improve health.
Funding: Bill & Melinda Gates Foundation.
Comment on
-
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.Lancet. 2013 Jul 6;382(9886):50-6. doi: 10.1016/S0140-6736(13)60856-9. Epub 2013 May 15. Lancet. 2013. PMID: 23683600 Free PMC article. Clinical Trial.
Similar articles
-
Osteoporosis: Teriparatide and denosumab: two drugs are better than one!Nat Rev Rheumatol. 2013 Jul;9(7):383. doi: 10.1038/nrrheum.2013.79. Epub 2013 May 28. Nat Rev Rheumatol. 2013. PMID: 23712125 No abstract available.
-
[Combination therapy in postmenopausal osteoporosis leads to denser bones than monotherapy].Praxis (Bern 1994). 2013 Sep 18;102(19):1203-4. doi: 10.1024/1661-8157/a001403. Praxis (Bern 1994). 2013. PMID: 24025179 German. No abstract available.
-
Oséoporose: tériparatide + dénosumab augmentent plus la densité minérale osseuse que chacun des médicaments adminitsré seul.Rev Prat. 2013 Sep;63(7):924. Rev Prat. 2013. PMID: 24167890 French. No abstract available.
-
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.Pharmacotherapy. 2011 May;31(5):510-23. doi: 10.1592/phco.31.5.510. Pharmacotherapy. 2011. PMID: 21923432 Review.
-
[Treatment of osteoporosis with PTH].Clin Calcium. 2014 Jun;24(6):893-902. Clin Calcium. 2014. PMID: 24870841 Review. Japanese.
Cited by
-
Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis.Front Pharmacol. 2022 Jun 14;13:938447. doi: 10.3389/fphar.2022.938447. eCollection 2022. Front Pharmacol. 2022. PMID: 35774616 Free PMC article. Review.
-
Innovations in Women's Bone Health-Appreciating Important "Bone Variables" Besides Estrogen.Int J Environ Res Public Health. 2018 Sep 5;15(9):1929. doi: 10.3390/ijerph15091929. Int J Environ Res Public Health. 2018. PMID: 30189600 Free PMC article. No abstract available.
-
Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization.J Musculoskelet Neuronal Interact. 2017 Sep 1;17(3):146-154. J Musculoskelet Neuronal Interact. 2017. PMID: 28860416 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
